本頁面由Tiger Trade Technology Pte. Ltd.提供服務

ANI Pharmaceuticals, Inc.

75.06
+1.472.00%
成交量:19.56萬
成交額:1,460.20萬
市值:17.24億
市盈率:16.53
高:75.20
開:73.68
低:73.54
收:73.59
52周最高:98.55
52周最低:69.58
股本:2,297.04萬
流通股本:2,028.20萬
量比:0.78
換手率:0.96%
股息:- -
股息率:- -
每股收益(TTM):4.54
每股收益(LYR):3.32
淨資產收益率:20.46%
總資產收益率:5.45%
市淨率:2.89
市盈率(LYR):22.61

資料載入中...

2024/05/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/14

重要事件披露

Form 8-K - Current report
2024/05/10

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/10

重要事件披露

Form 8-K - Current report
2024/04/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/17

重要事件披露

Form 8-K - Current report
2024/04/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/14

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/03/12

重要事件披露

Form 8-K - Current report
2024/03/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities